The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of the toll-like receptor 5 (TLR5) agonist, entolimod in patients (pts) with advanced cancers.
 
Hatoon Bakhribah
No Relationships to Disclose
 
Grace K. Dy
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merrimack (Inst); Novartis (Inst); OncoMed (Inst)
 
Wen Wee Ma
No Relationships to Disclose
 
Yujie Zhao
No Relationships to Disclose
 
Mateusz Opyrchal
No Relationships to Disclose
 
Andrei Purmal
No Relationships to Disclose
 
Sandra Gollnick
No Relationships to Disclose
 
William E. Brady
No Relationships to Disclose
 
Gerald J. Fetterly
No Relationships to Disclose
 
Nuttapong Ngamphaiboon
No Relationships to Disclose
 
Thanyanan Reungwetwattana
No Relationships to Disclose
 
Sandra M Jacob
No Relationships to Disclose
 
Corrie O'Hara
No Relationships to Disclose
 
Francine Siedlecki
No Relationships to Disclose
 
Araba Adjei
No Relationships to Disclose
 
Lyudmila Burdelya
No Relationships to Disclose
 
Ivan Bespalov
No Relationships to Disclose
 
Langdon L. Miller
Consulting or Advisory Role - Cleveland BioLabs
 
Andrei Gudkov
Employment - Cleveland BioLabs
Leadership - Cleveland BioLabs
Stock and Other Ownership Interests - Cleveland BioLabs
Consulting or Advisory Role - Cleveland BioLabs
Research Funding - Cleveland BioLabs (Inst)
Patents, Royalties, Other Intellectual Property - Cleveland BioLabs (Inst)
 
Alex A. Adjei
No Relationships to Disclose